Point Of Care Hematology Diagnostics Market Outlook Highlighting Key Drivers And Market Evolution
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Large Will The Point Of Care Hematology Diagnostics Market Be By 2030 Compared To Its 2026 Market Size?
The point of care hematology diagnostics market size has demonstrated strong growth in recent years. It is anticipated to increase from $2.9 billion in 2025 to $3.16 billion in 2026, registering a compound annual growth rate (CAGR) of 9.0%. The expansion observed in the historical period can be attributed to factors such as reliance on centralized laboratory testing, the increasing prevalence of anemia and blood disorders, a rise in hospital emergency admissions, the demand for faster diagnostic turnaround, and restricted access to laboratory infrastructure in rural areas.
The point of care hematology diagnostics market is anticipated to show significant expansion in the upcoming years. It is forecast to grow to $4.39 billion in 2030, with a compound annual growth rate (CAGR) of 8.6%. The expansion during this forecast period stems from factors such as the increasing occurrence of chronic and infectious diseases, the broadening of point of care testing programs, a heightened need for swift diagnostics in emergency care, innovations in compact hematology analyzers, and the development of decentralized healthcare delivery models. Noteworthy trends expected in this period include the rising acceptance of rapid bedside blood testing, an increasing need for decentralized diagnostics in urgent settings, the growing utilization of portable and handheld hematology devices, the spread of point of care testing in areas with limited resources, and an emphasis on faster results for clinical decisions.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Drivers Are Fueling The Growth Of The Point Of Care Hematology Diagnostics Market?
The rising prevalence of blood disorders is expected to propel the growth of the point-of-care hematology diagnostics market going forward. Blood disorders refer to conditions that affect the components of blood, including red blood cells, white blood cells, platelets, or plasma. The increasing incidence of blood disorders is primarily due to the rising prevalence of chronic diseases, which directly impact blood health and require ongoing monitoring. Point-of-care hematology diagnostics help in the timely detection and monitoring of blood disorders by providing rapid, accurate results at or near the site of patient care, enabling quicker clinical decisions and improved disease management. For instance, in November 2024, according to The American Society of Hematology, a US-based Non-profit organization, projected that global leukemia cases could increase to approximately 519,540 by 2050. Therefore, the rising incidence of blood disorders is driving the growth of the point-of-care hematology diagnostics market.
What Are The Different Segment Types In The Point Of Care Hematology Diagnostics Market Segment Breakdown?
The point of care hematology diagnostics market covered in this report is segmented –
1) By Type: Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types
2) By Mode Of Prescription: Prescription Based Product, Over-The-Counter Based Product
3) By End User: Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users
Subsegments:
1) By Complete Blood Count: White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)
2) By Coagulation Testing: Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level
3) By Hemoglobin Testing: Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin
4) By Anemia Diagnosis: Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation
5) By Other Types: Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, C-Reactive Protein Testing
What Trends Are Influencing The Point Of Care Hematology Diagnostics Market?
Major companies operating in the point-of-care hematology diagnostics market are concentrating on creating cutting-edge products, such as cartridge-based AI-powered hematology analyzers, to facilitate quick, precise, and on-site blood analysis, thereby enhancing patient care. These compact diagnostic devices employ single-use reagent cartridges and artificial intelligence algorithms to swiftly and accurately analyze blood samples directly at the point of care. For instance, in September 2024, Zoetis Inc., a US-based veterinary health company, introduced Vetscan OptiCell, a cartridge-based, AI-powered hematology analyzer specifically designed for veterinary applications. This innovative system delivers rapid, reference laboratory-quality complete blood count (CBC) results within minutes at the point of care, while simultaneously reducing maintenance and manual operation time. It is equipped with sophisticated AI-driven image analysis and viscoelastic focusing technology, which precisely aligns cells for clear imaging, enabling accurate blood cell classification and automated abnormality detection, thus ensuring efficient and reliable veterinary diagnostics.
Who Are The Well-Known Companies In The Point Of Care Hematology Diagnostics Market?
Major companies operating in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton Dickinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, Bio-Rad Laboratories Inc.
Get The Full Point Of Care Hematology Diagnostics Market Report:
Which Region Has The Greatest Market Share In The Point Of Care Hematology Diagnostics Market?
North America was the largest region in the point of care hematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care hematology diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Point Of Care Hematology Diagnostics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Point Of Care Hematology Diagnostics Market 2026, By The Business Research Company
Architectural And Structural Metals Market Report 2026
Architectural And Structural Metals Market Report 2026
Buildings Construction Market Report 2026
https://www.thebusinessresearchcompany.com/report/buildings-construction-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
